Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
A University of Oxford report dated 9 October 2026 describes how the enzyme isopenicillin N synthase (IPNS) converts a linear peptide toward the ring-based core of penicillin. Using time-resolved X-ray free-electron laser (XFEL) experiments, the team captured two short-lived intermediates along the way: a thioaldehyde just before the β-lactam ring forms, and a monocyclic β-lactam, the first ring-shaped structure on the route to the complete scaffold. The results were published in Nature Catalysis in 2026, and the “molecular movie” is a sequence of snapshots assembled into a frame-by-frame account of that reaction.
The headline’s word “finally” overstates the case. IPNS has been studied in motion before, including a 2021 study, so this work adds a more detailed reaction sequence rather than a first look at the enzyme.
Where IPNS fits in penicillin production
Penicillin is made by living organisms through a multi-step biosynthetic pathway, not by a single chemical reaction in a flask. IPNS is one enzyme on that pathway. It takes a linear peptide precursor and drives the chemistry that closes it into the ring structures that define penicillin’s antibiotic core. Because the enzyme’s job is to shape that core, understanding its step-by-step behaviour is a question about how nature assembles the molecule, which is what the report’s authors set out to examine.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
The two intermediates
Intermediates are the transient species that exist between the starting material and the final product. The report identifies two of them in the IPNS reaction:
#1 Best Overall
| Intermediate | Where it sits in the reaction | Significance reported by the Oxford account |
|---|---|---|
| Thioaldehyde | Immediately before the β-lactam ring forms | Shows the chemistry in the stage just prior to ring closure |
| Monocyclic β-lactam | After ring formation, before the full scaffold is complete | The first ring-shaped structure on the route to the complete penicillin scaffold |
Both species are short-lived, which is why they had not been captured by conventional static structural methods. The report describes them as unanticipated, meaning they were not what the team expected to see.
How the molecular movie was made
The method depends on timing. Enzyme microcrystals are kept anaerobic, meaning free of oxygen, so the reaction does not start early. The experiment then proceeds as follows:
- Droplets containing the anaerobic enzyme microcrystals are deposited onto a moving tape that is 2 mm wide.
- The tape carries the droplets into an oxygen-filled chamber.
- Oxygen diffuses into the crystals and starts the reaction.
- The team varies the tape speed, which sets how long the crystals have been reacting before they reach the X-ray pulse.
- Each XFEL pulse records a snapshot of the enzyme at a particular reaction time.
- Thousands of these snapshots are combined into a sequence showing how the structure changes over time.
The “movie” is therefore a reconstruction built from many time-resolved crystal structures, not a video recording of a single molecule. The report states that the method captured these fleeting intermediates at atomic resolution under physiological temperature and pressure. The published account does not give the exact time points used for each frame, so the timing of individual steps should not be read from the headline.
What the movie suggests about the reaction
The report’s mechanistic interpretation is that water molecules inside the enzyme help guide the reaction, and that subtle movements throughout the enzyme contribute to it. These are interpretations drawn from the observed structures rather than a fully detailed, atom-by-atom account of each bond change. Readers should treat them as the authors’ current model of IPNS catalysis.
How this builds on earlier IPNS work
| Year | Study | Methods | Focus reported |
|---|---|---|---|
| 2021 | Berkeley Lab research report on IPNS dynamics | Complementary X-ray methods | Correlated motion and oxygen chemistry in the enzyme |
| 2022 | Primary research article, available through PubMed Central | Not stated in the account reviewed | Not stated in the account reviewed |
| 2026 | University of Oxford study in Nature Catalysis | Time-resolved XFEL snapshots of reacting microcrystals | Two short-lived intermediates and a more detailed reaction sequence |
The 2026 study extends this line of work by observing the intermediates directly during catalysis. It is a continuation of earlier IPNS dynamics research, not a replacement for it.
What the finding does and does not change
The report presents the work as basic mechanistic research. Its stated relevance is twofold. First, a clearer picture of how the enzyme shapes its product may inform enzyme engineering and catalyst design. Second, the researchers see possible relevance to future antibiotic development.
The study does not describe a new antibiotic, a treatment, a clinical trial, or evidence that existing antibiotics can now be made more effective. Readers looking for a medical result should not infer one from this report.
The researchers’ view
Christopher Schofield, professor of chemistry at the University of Oxford and a senior author, said: “Penicillin has shaped modern medicine, but there is still much to learn about how nature builds this important antibiotic structure.” The Oxford account attributes the statement to him; it does not establish whether the quote first appeared in a separate interview or press statement.
Quick Recap
Limits of this account
- The Oxford report is the main source for the findings described here. The journal page for the paper, DOI 10.1038/s41929-026-01618-4, was not accessible for this article, so the detailed mechanistic claims rest on the report’s description rather than on a reviewed full text.
- The report places the work within the wider context of β-lactam antibiotics and resistance. It includes a claim that one in six bacterial infections is resistant, but it does not identify the original publisher of that figure, so it is not repeated here as an established statistic.
- Exact per-frame timings and the full author list are not included in the public account.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
